PDZK1 and metastatic malignant neoplasm in the lymph nodes: TNBC patients with lower PDZK1 levels had a higher rate of lymph node metastasis and shorter overall survival (OS) time (Fig. 4E, F), suggesting that PDZK1 can serve as a predictor of metastasis and a poor prognosis in TNBC patients.